President Trump’s two business councils were already on shaky ground Wednesday.
By early afternoon, both had fallen apart.
“Rather than putting pressure on the businesspeople of the Manufacturing Council & Strategy & Policy Forum, I am ending both,” Trump tweeted at 1:14 p.m. ET “Thank you all!”
The Twitter announcement marked a stunning collapse for the two panels, the Manufacturing Jobs Initiative and the Strategic and Policy Forum. Trump hoped the two would help advise him on jobs and the economy.
The CEOs of Tesla (TSLA), Disney (DIS) and Uber had already abandoned the groups earlier this year over policy disagreements with Trump. But the two councils had largely stayed intact.
That started changing early Monday morning when Merck (MRK) CEO Kenneth Frazier abruptly resigned from the manufacturing council. His move came after Trump on Saturday blamed “many sides” for violence at a white nationalist rally in Charlottesville, Virginia.
investing in stocks: Ameresco, Inc.(AMRC)
Advisors’ Opinion:
- [By Jason Hall]
WhenAmeresco Inc(NYSE:AMRC) reported financial and operating results for its fourth quarter and fiscal year 2016 on March 2, the market was ecstatic, pushing shares up more than 17% on a combination of beating analyst expectations for profits, a solid order backlog for future business, and continued optimism around infrastructure investment in coming years.
- [By Lisa Levin]
Shares of Ameresco Inc (NYSE: AMRC) got a boost, shooting up 16 percent to $6.05 after the company reported strong Q4 results.
Navigator Holdings Ltd (NYSE: NVGS) shares were also up, gaining 23 percent to $13.50 on better-than-expected quarterly earnings.
- [By Manikandan Raman]
There also some lesser known clean energy stocks that may witness downward movement on potential Trump win on negative sentiment. They include Pattern Energy Group Inc (NASDAQ: PEGI), Enviva Partners LP (NYSE: EVA), TerraForm Global Inc (NASDAQ: GLBL), Renewable Energy Group Inc (NASDAQ: REGI) and Ameresco Inc (NYSE: AMRC).
investing in stocks: Jersey Elec.(a)
Advisors’ Opinion:
- [By Dave and Donald Moenning]
For those investors that like the comfort generally provided by a diversified portfolio, here’s an idea that will allow you to (a) maintain a diversified allocation in your portfolio and (b) stay out of trouble when the big, bad bears come to call on an asset class or two.
- [By Sujan Lahiri]
(A)
The first stage is the removal (harvesting) of a sliver of dermal tissue, called a micro-organ (2-3mm diameter x 30-40mm length), from beneath the patient’s skin. This procedure is performed under a local anesthetic, is intended to be performed in a physician’s office and is minimally invasive, so as to encourage rapid healing with little or no scarring. Generally, more than one micro-organ will be harvested from the patient (typically 4-5).
- [By Monica Gerson]
Agilent Technologies (NYSE: A) shares rose 5.45% to $52.01. The volume of Agilent Technologies shares traded was 736% higher than normal. Agilent announced its plans to separate into two public companies.
investing in stocks: Medical Marijuana, Inc. (MJNA)
Advisors’ Opinion:
- [By Peter Graham]
A long term performance chart shows GW Pharmaceuticals PLC outperforming other small cap marijuana stocks like Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE), Cannabis Science Inc (OTCMKTS: CBIS) and Medical Marijuana Inc (OTCMKTS: MJNA), but that outperformance has come withconsiderable volatility:
- [By Peter Graham]
A long term performance chart shows GW Pharmaceuticals PLC outperforming other marijuana stocks like Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE), Cannabis Science Inc (OTCMKTS: CBIS) and Medical Marijuana Inc (OTCMKTS: MJNA), but shares are also once again falling off from all-time highs:
- [By SEEKINGALPHA.COM]
Recommendation #3 Worked Well – I also recommended that you “buy” any marijuana stocks you liked in late December and in anticipation of late December 2016 tax loss selling followed by a January effect increase in price-per-share or recovery. That is the topic of this article. I also had a few stock picks: (1) Cannabix Technologies (OTCPK:BLOZF) is up 10%, (2) Breathtec Biomed (OTCQB:BTHCF) is up 13%, (3) Bayport International (OTCPK:BAYP) is flat, though news might result in an increase by month end – this is a risky one, and (4) Medical Marijuana (OTCPK:MJNA) is up 6%.
- [By Sean Williams]
This rapid growth in legal pot has create quite the demand for marijuana stocks. The seven largest marijuana stocks by market cap have all put on a show over the past couple of years. Here are those seven “green giants” listed with their market caps as of March 17, 2017, along with their trailing one-year total returns.
GW Pharmaceuticals (NASDAQ:GWPH): $3.0 billion, up 64% Canopy Growth Corp. (NASDAQOTH:TWMJF): $904 million, up 259% Aphria (NASDAQOTH:APHQF) $440 million, up 381% Aurora Cannabis (NASDAQOTH:ACBFF): $482 million, up 299% AXIM Biotechnologies (NASDAQOTH:AXIM): $562 million, up 1,720% Corbus Pharmaceuticals (NASDAQ:CRBP): $450 million, up 431% Medical Marijuana (NASDAQOTH:MJNA): $221 million, up 254%
As you can see, these are some hefty valuations — and some exceptionally strong moves higher on the heels of marijuana’s expansion. With the exception of GW Pharmaceuticals, every one of the largest marijuana stocks has at least tripled in value over the trailing 12 months, with cannabinoid-based drug developer AXIM Biotechnologies skyrocketing more than 1,700%!
- [By Jim Robertson]
When investors think of cannabinoid or marijuana stocks, they either think of better known stocks likeGW Pharmaceuticals PLC (NASDAQ: GWPH)and Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) that trade on bigger exchanges orCannabis Science Inc (OTCMKTS: CBIS) and Medical Marijuana Inc (OTCMKTS: MJNA) that are stilllisted on the OTC. However, there are other more indirect ways to invest in growing cannabinoid or marijuana acceptance.
investing in stocks: CASI Pharmaceuticals, Inc.(CASI)
Advisors’ Opinion:
- [By Jim Robertson]
US based but China focused small cap biopharmaceutical stockCASI Pharmaceuticals (NASDAQ: CASI) is up around 78% over the last three trading days on no apparent news on the newswires as the following chart illustrates:
- [By Lisa Levin]
CASI Pharmaceuticals Inc (NASDAQ: CASI) shares shot up 62 percent to $3.61 following disclosure company Director He Wei-Wu purchased 200,000 shares on October 5 and 6. The stock rallied 15 percent on no news during Tuesday's intraday session.
investing in stocks: Infinera Corporation(INFN)
Advisors’ Opinion:
- [By Tracey Ryniec]
Infinera isn’t in a glamorous part of the technology business, as it provides fiber optic connection gear, but as companies like Amazon and Facebook need and use ever more data, it’s Infinera which paves the way. Earnings are expected to grow 31% in 2016.
- [By Billy Duberstein]
What a year 2016 was for Infinera (NASDAQ:INFN) shareholders. The stock plunged over 50% last year, as its multiyear run of accelerating 20%-30% growth rates ground to a halt. The story changed from that of a high-growth technology company riding the secular trend of exploding data and bandwidth needs to one of stagnating revenues, profits turning to losses, increased competition, and end customers pausing investments in optical networks.
- [By Brian Feroldi]
Investing in the tech sector can be tricky. Competition tends to be fierce, which makes it difficult to stay one step ahead. Two companies that have a strong history of maintaining their edge are Skyworks Solutions(NASDAQ:SWKS)and Infinera(NASDAQ:INFN). Both of these businesses have been taking market share in their industries for years, which is impressive. But which of these two tech companies is the better investment today? Let’s review the bull thesis for each company so we can make an informed decision.
- [By Lisa Levin]
Infinera Corp. (NASDAQ: INFN) shares were also up, gaining 27 percent to $11.92 after the company reported stronger-than-expected Q4 results.
Equities Trading DOWN
investing in stocks: Treehouse Foods, Inc.(THS)
Advisors’ Opinion:
- [By WWW.THESTREET.COM]
In the Lightning Round, Cramer was bullish on Treehouse Foods (THS) , TG Therapeutics (TGTX) , Kinder Morgan (KMI) , Magellan Midstream Partners (MMP) , Chesapeake Energy (CHK) and Arconic (ARNC) .
